Flashback Foreword: Chimeric Anti-CD20 Monoclonal Antibody Therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2023-01, Vol.41 (2), p.151-152
1. Verfasser:	Friedberg, Jonathan W
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - therapeutic use Antigens, CD20 Antineoplastic Agents Humans Rituximab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	152
container_issue	2
container_start_page	151
container_title	Journal of clinical oncology
container_volume	41
creator	Friedberg, Jonathan W
description
doi_str_mv	10.1200/JCO.22.02425
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2761973641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2761973641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c248t-951a3d1325c46aedaff2f5229f72396a80e90d9431637423d75befed48d59f3a3</originalsourceid><addsrcrecordid>eNo9kD1PwzAURS0EoqWwMaOMDKTY79lxwlYC5UNFXYrEZjmxrQaSutitUP89hRamK10dneEQcs7okAGl18_ldAgwpMBBHJA-EyBTKYU4JH0qEVKW41uPnMT4TinjOYpj0sMsoyg47ZPbcavjvNL1RzL2wX75YG6Sct50NjR1MlqsmrS8A5q8-IWvW7_Q7e9ZebNJZnMb9HJzSo6cbqM92--AvI7vZ-VjOpk-PJWjSVoDz1dpIZhGwxBEzTNtjXYOnAAonAQsMp1TW1BTcGQZSg5opKiss4bnRhQONQ7I5c67DP5zbeNKdU2sbdvqhfXrqEBmrJCYcbZFr3ZoHXyMwTq1DE2nw0Yxqn6qqW01BaB-q23xi715XXXW_MN_mfAbocxlmQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2761973641</pqid></control><display><type>article</type><title>Flashback Foreword: Chimeric Anti-CD20 Monoclonal Antibody Therapy</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Friedberg, Jonathan W</creator><creatorcontrib>Friedberg, Jonathan W</creatorcontrib><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.22.02425</identifier><identifier>PMID: 36603540</identifier><language>eng</language><publisher>United States</publisher><subject>Antibodies, Monoclonal - therapeutic use ; Antigens, CD20 ; Antineoplastic Agents ; Humans ; Rituximab</subject><ispartof>Journal of clinical oncology, 2023-01, Vol.41 (2), p.151-152</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c248t-951a3d1325c46aedaff2f5229f72396a80e90d9431637423d75befed48d59f3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3716,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36603540$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Friedberg, Jonathan W</creatorcontrib><title>Flashback Foreword: Chimeric Anti-CD20 Monoclonal Antibody Therapy</title><title>Journal of clinical oncology</title><addtitle>J Clin Oncol</addtitle><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antigens, CD20</subject><subject>Antineoplastic Agents</subject><subject>Humans</subject><subject>Rituximab</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kD1PwzAURS0EoqWwMaOMDKTY79lxwlYC5UNFXYrEZjmxrQaSutitUP89hRamK10dneEQcs7okAGl18_ldAgwpMBBHJA-EyBTKYU4JH0qEVKW41uPnMT4TinjOYpj0sMsoyg47ZPbcavjvNL1RzL2wX75YG6Sct50NjR1MlqsmrS8A5q8-IWvW7_Q7e9ZebNJZnMb9HJzSo6cbqM92--AvI7vZ-VjOpk-PJWjSVoDz1dpIZhGwxBEzTNtjXYOnAAonAQsMp1TW1BTcGQZSg5opKiss4bnRhQONQ7I5c67DP5zbeNKdU2sbdvqhfXrqEBmrJCYcbZFr3ZoHXyMwTq1DE2nw0Yxqn6qqW01BaB-q23xi715XXXW_MN_mfAbocxlmQ</recordid><startdate>20230110</startdate><enddate>20230110</enddate><creator>Friedberg, Jonathan W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230110</creationdate><title>Flashback Foreword: Chimeric Anti-CD20 Monoclonal Antibody Therapy</title><author>Friedberg, Jonathan W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c248t-951a3d1325c46aedaff2f5229f72396a80e90d9431637423d75befed48d59f3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antigens, CD20</topic><topic>Antineoplastic Agents</topic><topic>Humans</topic><topic>Rituximab</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Friedberg, Jonathan W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Friedberg, Jonathan W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Flashback Foreword: Chimeric Anti-CD20 Monoclonal Antibody Therapy</atitle><jtitle>Journal of clinical oncology</jtitle><addtitle>J Clin Oncol</addtitle><date>2023-01-10</date><risdate>2023</risdate><volume>41</volume><issue>2</issue><spage>151</spage><epage>152</epage><pages>151-152</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><cop>United States</cop><pmid>36603540</pmid><doi>10.1200/JCO.22.02425</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0732-183X
ispartof	Journal of clinical oncology, 2023-01, Vol.41 (2), p.151-152
issn	0732-183X 1527-7755
language	eng
recordid	cdi_proquest_miscellaneous_2761973641
source	MEDLINE; American Society of Clinical Oncology Online Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects	Antibodies, Monoclonal - therapeutic use Antigens, CD20 Antineoplastic Agents Humans Rituximab
title	Flashback Foreword: Chimeric Anti-CD20 Monoclonal Antibody Therapy
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T23%3A05%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Flashback%20Foreword:%20Chimeric%20Anti-CD20%20Monoclonal%20Antibody%20Therapy&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=Friedberg,%20Jonathan%20W&rft.date=2023-01-10&rft.volume=41&rft.issue=2&rft.spage=151&rft.epage=152&rft.pages=151-152&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.22.02425&rft_dat=%3Cproquest_cross%3E2761973641%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2761973641&rft_id=info:pmid/36603540&rfr_iscdi=true